Nomad Power Solutions, Inc. SEC filings NMAD
Nomad Power Solutions, Inc. has 528 filings in SEC EDGAR's recent list, going back to Aug 3, 2005. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Jul 27, 2026 | Jul 27, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 17, 2026 | Jul 17, 2026 |
| DEFA14A | Additional proxy material | Oct 28, 2025 | — |
| DEF 14A | Proxy statement | Oct 27, 2025 | Oct 27, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 16, 2025 | Oct 16, 2025 |
| DEFA14A | Additional proxy material | Nov 5, 2024 | — |
| DEF 14A | Proxy statement | Nov 5, 2024 | Nov 4, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 23, 2024 | Oct 23, 2024 |
| DEFA14A | Additional proxy material | Oct 10, 2023 | — |
| DEF 14A | Proxy statement | Oct 10, 2023 | Oct 10, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 29, 2023 | Sep 29, 2023 |
| DEF 14A | Proxy statement | Apr 11, 2023 | Apr 11, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 24, 2023 | Mar 24, 2023 |
| DEFA14A | Additional proxy material | Aug 26, 2022 | — |
| DEF 14A | Proxy statement | Aug 26, 2022 | Aug 26, 2022 |
| PRE 14A | Preliminary proxy statement | Aug 16, 2022 | Aug 15, 2022 |
| DEFA14A | Additional proxy material | May 25, 2021 | — |
| DEF 14A | Proxy statement | May 25, 2021 | May 24, 2021 |
| PRE 14A | Preliminary proxy statement | May 13, 2021 | May 13, 2021 |
| DEF 14C | Information statement | Aug 31, 2020 | Aug 31, 2020 |
| PRE 14C | Filing | Aug 11, 2020 | Aug 11, 2020 |
| DEF 14C | Information statement | Sep 19, 2006 | Sep 20, 2006 |
| PRE 14C | Filing | Sep 1, 2006 | Aug 8, 2006 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NMAD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boca Raton, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1335105
- Former names
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (until Jul 2, 2026); SRKP 7 INC (until Dec 1, 2006)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.